Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy

Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy

Source: 
Xconomy
snippet: 

Novome Biotechnologies is developing a gut microbiome treatment for hyperoxaluria. The company is engineering bacteria intended to populate the gut and then break down the key molecule before it causes problems.